1,974 Shares in CME Group Inc. $CME Acquired by First Nebraska Trust Co

First Nebraska Trust Co bought a new stake in shares of CME Group Inc. (NASDAQ:CME) during the 2nd quarter, Holdings Channel reports. The firm bought 1,974 shares of the financial services provider’s stock, valued at approximately $436,000.

A number of other hedge funds also recently bought and sold shares of the company. Empowered Funds LLC increased its position in CME Group by 11.5% in the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after buying an additional 1,037 shares in the last quarter. Marshall Wace LLP increased its holdings in shares of CME Group by 103.1% in the 2nd quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock worth $1,018,000 after buying an additional 121,707 shares during the last quarter. Federated Hermes Inc. increased its position in shares of CME Group by 1,325.2% during the 2nd quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock valued at $6,497,000 after purchasing an additional 21,918 shares during the last quarter. Nebula Research & Development LLC purchased a new stake in shares of CME Group in the second quarter valued at $992,000. Finally, The Manufacturers Life Insurance Company lifted its stake in CME Group by 2.6% in the second quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock worth $79,344,000 after purchasing an additional 7,397 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Price Performance

CME Group stock opened at $274.98 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm’s 50-day simple moving average is $251.17 and its 200 day simple moving average is $279.65. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16. The firm has a market capitalization of $98.88 billion, a PE ratio of 23.32, a P/E/G ratio of 3.20 and a beta of 0.23.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the previous year, the firm posted $2.96 EPS. CME Group’s revenue was up .8% on a year-over-year basis. On average, equities research analysts predict that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be paid a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s payout ratio is presently 44.11%.

Insider Activity at CME Group

In other CME Group news, Director William R. Shepard purchased 325 shares of CME Group stock in a transaction on Thursday, June 25th. The stock was bought at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the transaction, the director owned 260,442 shares of the company’s stock, valued at $60,050,111.94. The trade was a 0.12% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. Raymond James Financial reissued an “outperform” rating and set a $320.00 price target on shares of CME Group in a research report on Thursday, July 2nd. Weiss Ratings lowered shares of CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, August 11th. Deutsche Bank Aktiengesellschaft downgraded CME Group from a “buy” rating to a “hold” rating and decreased their target price for the company from $286.00 to $270.00 in a research report on Wednesday. Morgan Stanley upped their target price on CME Group from $324.00 to $330.00 and gave the company an “overweight” rating in a report on Thursday, July 23rd. Finally, Piper Sandler decreased their target price on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 15th. Nine analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, CME Group currently has an average rating of “Hold” and a consensus price target of $288.56.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.